PyInvesting

Market research

1093.HK CSPC Pharmaceutical Group Limited

Current ticker: 1093.HK

HK HKD Healthcare

Latest close

7.92 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
90B
P/E ratio
10.85
Analyst target
12.5668
Dividend yield
3.5%
Beta
0.77

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

CSPC Pharmaceutical Group Limited is currently in a long term uptrend where the price is trading 12.7% above its 200 day moving average.

From a valuation standpoint, the stock is 96.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.

CSPC Pharmaceutical Group Limited's total revenue rose by 7.2% to $6B since the same quarter in the previous year.

Its net income has increased by 81.8% to $2B since the same quarter in the previous year.

Finally, its free cash flow grew by 46.2% to $2B since the same quarter in the previous year.

Based on the above factors, CSPC Pharmaceutical Group Limited gets an overall score of 5/5.